Publications by authors named "Motoko Tamura"

Claim this Profile
T
Treatment status and safety of crizotinib in 2028 Japanese patients with ALK-positive NSCLC in clinical settings.
Naomi Ueno, Shigeo Banno, Yutaka Endo, Motoko Tamura, Katsuko Sugaya

Jpn J Clin Oncolยท July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis